PRACTICAL ONCOLOGY JOURNAL ›› 2015, Vol. 29 ›› Issue (1): 69-72.doi: 10.11904/j.issn.1002-3070.2015.01.015

• Review • Previous Articles     Next Articles

Combined chemotherapy of irinotecan/platinum in extensive disease SCLC

ZHU Xiaofeng,ZHU Jiemei   

  1. Department of TCM,Changshu NO.1 People′s Hospital,Changshu 215500,China
  • Received:2014-08-24 Online:2015-02-28 Published:2015-03-06

Abstract: Small cell lung cancer(SCLC),characterized with rapid growth and early metastasis,accounts for about 15~20 percent of all kinds of lung cancer.Patients with extensive disease of SCLC should be treated with combined chemotherapy.The standard treatment for extensive SCLC is etoposide combined with platinum,shortly for EP,with no breakthrough progress in the last decades.This paper briefly reviews the combination of irinotecan/platinum that showed effectiveness and safety in the treatment of extensive SCLC.

CLC Number: